| 注册
首页|期刊导航|中国临床药理学杂志|重组表皮生长因子治疗外伤性鼓膜穿孔患者的临床研究

重组表皮生长因子治疗外伤性鼓膜穿孔患者的临床研究

王丹凤 吕建刚 孙岚

中国临床药理学杂志2025,Vol.41Issue(5):641-645,5.
中国临床药理学杂志2025,Vol.41Issue(5):641-645,5.DOI:10.13699/j.cnki.1001-6821.2025.05.009

重组表皮生长因子治疗外伤性鼓膜穿孔患者的临床研究

Clinical trail of recombinant epidermal growth factor in the treatment of patients with traumatic tympanic membrane perforation

王丹凤 1吕建刚 1孙岚1

作者信息

  • 1. 郑州市中医院 耳鼻咽喉科,河南郑州 450000
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and safety of recombinant epidermal growth factor(rhEGF)gel combined with gelatin sponge application under ear endoscopy in the treatment of traumatic tympanic membrane perforations.Methods Patients with traumatic tympanic membrane perforations were divided into control group and treatment group using cohort method.The control group received intravenous infusion of clindamycin phosphate injection(0.9 g,once daily).The treatment group received rhEGF gel(1 drop per dose,twice daily)combined with gelatin sponge application under ear endoscopy.Both groups received treatment for 1 week.The clinical efficacy,inflammatory markers[white blood cell count(WBC),C-reactive protein(CRP)],hearing status,and safety were compared between the two groups.Results A total of 37 patients in the control group and 43 patients in the treatment group were enrolled.The overall treatment efficacy in the treatment and control groups were 95.35%(41 cases/43 cases)and 78.38%(29 cases/37 cases),respectively,with statistically significant difference(P<0.05).After treatment,the WBC levels in the treatment and control groups were(7.74±1.47)and(10.68±1.64)× 10·L-1,respectively;the CRP levels were(3.37±0.97)and(6.35±1.01)pg·mL-1,respectively;the air conduction hearing thresholds were(25.64±2.13)and(29.68±2.24)dB HL,respectively;and the air-bone conduction gap were(6.54±1.24)and(12.36±2.47)dB,respectively.The treatment group showed statistically significant differences in all these indicators compared to the control group(all P<0.05).The adverse drug reactions in the treatment group,the main adverse drug reaction was infection,while in the control group mainly included infection and re-perforation.The incidence of adverse drug reactions in the treatment and control groups were 4.65%(2 cases/43 cases)and 10.81%(4 cases/37 cases),respectively,with no significant difference(P>0.05).Conclusion The clinical efficacy of treating patients with traumatic tympanic membrane perforation by combining rhEGF gel with absorbable gelatin sponge patch is better than that of conservative treatment.It has a low incidence of adverse drug reactions and high safety.

关键词

重组表皮生长因子凝胶/吸收性明胶海绵/耳内镜/外伤性鼓膜穿孔/临床疗效

Key words

recombinant epidermal growth factor gel/gelatin sponge/otoendoscope/traumatic tympanic membrane perforation/clinical efficacy

分类

药学

引用本文复制引用

王丹凤,吕建刚,孙岚..重组表皮生长因子治疗外伤性鼓膜穿孔患者的临床研究[J].中国临床药理学杂志,2025,41(5):641-645,5.

中国临床药理学杂志

OA北大核心

1001-6821

访问量3
|
下载量0
段落导航相关论文